Acquisition of Group B streptococcus colonization in preterm pregnancy
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
The purpose of this study was to estimate the negative predictive value (NPV) of screening for group B streptococcus (GBS) colonization in pregnant patients undergoing antepartum hospitalization for GBS colonization status at the time of preterm delivery.
Study Design
This prospective, observational cohort study compared GBS colonization status upon initial hospital admission to that at the time of delivery. Pregnant patients at 22 to 35 weeks gestation admitted to the antepartum unit at a tertiary care hospital underwent standard screening for GBS colonization. When preterm labor progressed or iatrogenic preterm delivery was indicated, the GBS colonization test was repeated. Comparison of the sequential test results was performed to determine the NPV of the antepartum screening test for the intrapartum status.
Results
159 eligible patients were enrolled in the study, and 100 completed the study and were included in the analysis. The average gestational age at admission was 30 weeks 1 day (95% confidence interval [CI] 29w4d to 30w6d) and the average duration of pregnancy latency in the study group was 17.5 days (95% CI 15.1 to 19.8). GBS colonization rate at the time of admission was 18% and at the time of delivery was 20%. The NPV of GBS screening at admission was 91.5% (95% CI 83.2 to 96.5%) and the positive predictive value (PPV) was 72.2% (95% CI 46.4 to 90.3%).
Conclusion
In a cohort of pregnant patients with preterm pregnancy complications, GBS screening at the time of antepartum hospital admission has an NPV of 91.5% (95% CI 83.2 to 96.5%) for GBS colonization at the time of preterm delivery. This is comparable to the published NPV of routine GBS screening for colonization status at term delivery.
Key Points
-
Prevalence of GBS colonization was 18% at preterm hospital admission and 20% at preterm delivery.
-
The NPV of initial GBS screening for status at preterm delivery was 91.5%.
-
7 of 100 patients had false-negative GBS screening.